logo
Lyra Health Introduces Centers of Excellence to Help Employees Thrive Through Life's Most Challenging Moments

Lyra Health Introduces Centers of Excellence to Help Employees Thrive Through Life's Most Challenging Moments

Business Wire01-05-2025
BURLINGAME, Calif.--(BUSINESS WIRE)-- Lyra Health, the leading provider of innovative Workforce Mental Health solutions for employers, today introduced its Centers of Excellence (COEs), specialized programs designed to support the highest-need members through coordinated, expert-led care. Lyra's COEs deliver faster recovery and improved outcomes by connecting members to the right level of care early, reducing the need for costly interventions like emergency room visits and hospitalizations, and lowering total health care spend for employers.
The COE model builds on Lyra's core clinical foundation to support conditions where traditional systems often fall short, such as supporting neurodiverse individuals of all ages, women's mental health, and employees managing mental health needs alongside chronic conditions. Each Center connects members to a team of specialists—therapists, prescribing clinicians, coaches, and family support experts—who collaborate under structured care plans tailored to specific conditions. This approach delivers personalized support for members, while helping employers manage health care costs and reduce disability leaves.
'The mental health system often fails people when they need it most—during periods of profound change or crisis,' said Dr. Connie Chen, Chief Medical Officer, Lyra Health. 'Whether it's a parent navigating their child's new diagnosis, managing mental health alongside a chronic condition, or seeking support through experiences like fertility struggles, pregnancy, caregiving, or menopause, the journey can be overwhelming. Our Centers of Excellence bring structure, support, and science to these critical life moments, helping people get better, faster.'
Lyra's Centers of Excellence are built to help employees and families navigate a disconnected system, coordinating between therapists, psychiatrists, medical providers, and specialists. Each Center delivers condition-specific support grounded in clinical expertise, proactive care coordination, and personalized treatment plans that evolve with the individual.
Specialized Support Where It's Needed Most
Lyra is committed to addressing urgent and costly mental health needs that are increasingly common in today's workforce. Lyra's Centers of Excellence provide access to multidisciplinary support and replace fragmentation with structured, collaborative care:
Center of Excellence for Neurodiversity offers neuropsychological assessments, diagnosis and tailored care for ADHD, and support for autism and learning differences, designed for individuals, workplaces, and families
Center of Excellence supporting Chronic Conditions offers mental health care for members managing co-occurring conditions like chronic pain, cardiovascular disease, obesity, cancer, and sleep issues
Center of Excellence for Women's Mental Health delivers evidence-based, personalized support across every life stage for women—from menstrual health and fertility through pregnancy, postpartum, caregiving, and menopause
As mental health needs continue to evolve, Lyra will build on its COEs to both deepen existing areas of support and introduce new Centers, ensuring members and employers have access to comprehensive support across the full spectrum of needs.
Raising the Standard for Mental Health in the Workplace
Each Center is grounded in five foundational pillars:
Deep clinical expertise in-house, led by Lyra's network of evidence-based mental health providers specializing in fields like pediatrics, autism spectrum disorder, weight management, and women's mental health
Multi-disciplinary, team-based care with mental health professionals, physical health benefits providers, and health specialists collaborating directly to deliver seamless whole-person support, removing the burden of care coordination from the member
Measurable outcomes, with clear tracking of clinical progress, recovery timelines, and care quality to ensure members improve faster and employers see real impact
Standardized best practices based on evidence-based protocols, clinical research, and continuous quality improvement to drive consistent, high-quality care across every Center
Scalability and innovation, powered by AI and predictive analytics to personalize care pathways and adapt to evolving workforce needs
For more information about Lyra's Centers of Excellence, visit www.lyrahealth.com/platform/centers-of-excellence.
About Lyra Health
Lyra Health is the leading provider of Workforce Mental Health benefits, available to more than 20 million people globally. Lyra is transforming access to life-changing mental health care through Lyra Empower, the only fully integrated, AI-powered platform combining the highest-quality care and technology solutions for members, providers and HR leaders. Empower works in the background to quickly connect members to the largest global network of evidence-based mental health providers, deliver actionable insights to benefit leaders, and free up providers to focus on client care—driving outstanding positive outcomes that are equitable across diverse racial and ethnic groups. Extensive peer-reviewed research confirms Lyra's transformative care model helps people recover twice as fast and results in a 26% annual reduction in overall healthcare claims costs. For more information, visit lyrahealth.com.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Hope Realized: FDA Approves Papzimeos for Adults with Recurrent Respiratory Papillomatosis (RRP)
Hope Realized: FDA Approves Papzimeos for Adults with Recurrent Respiratory Papillomatosis (RRP)

Yahoo

time2 hours ago

  • Yahoo

Hope Realized: FDA Approves Papzimeos for Adults with Recurrent Respiratory Papillomatosis (RRP)

Papzimeos, the first-ever treatment approved for RRP is a moment for celebration and reflection FORT WORTH, Texas, August 15, 2025--(BUSINESS WIRE)--The Recurrent Respiratory Papillomatosis Foundation (RRPF) is excited to share the news that the U.S. Food and Drug Administration (FDA) has granted full approval to Precigen's Papzimeos (zopapogene imadenovec-drba) under Priority Review for the treatment of adults with Recurrent Respiratory Papillomatosis (RRP). Papzimeos is the first and only FDA-approved treatment for RRP. (See FDA's announcement here) A moment of profound healing for the RRP Community This is truly a remarkable day – the culmination of decades of advocacy, resilience, and unwavering commitment from patients, families, researchers, and supporters. The approval of the first non-surgical treatment for adults with RRP marks not only a scientific milestone, but an inflection point for the entire RRP community. We extend our deepest gratitude to the many individuals and institutions who helped make this breakthrough possible – from the investigators, NIH collaborators, and clinicians who advanced the science, to the industry partners, whose investment and commitment to this community helped bring this treatment to approval. The FDA's announcement is also a deeply personal victory for every voice that has spoken up, every surgery endured, and every hope held steadfast. At RRPF, we are honored to walk alongside this community, championing awareness, supporting research, and amplifying the lived experiences of those affected by this rare disease. We celebrate the light this approval brings and recommit ourselves to the journey ahead, ensuring that patients of every age and living beyond the U.S. can one day access safe, effective and nonsurgical treatments. "For decades, our community has persevered through an isolating journey of countless surgeries, silence, and uncertainty. Yet while we continued to breathe, we continued to hope. Today, our hope is realized. Today, with the approval of Papzimeos our hope is no longer a dream, it's a reality," said Kim McClellan, President of RRPF. "This is a moment of profound healing, not just for the body, but for the spirit of every adult living with RRP. We finally have an FDA-approved treatment that targets the root cause of RRP and with it, the chance for many members of our community to reclaim lives unencumbered by RRP." Quick facts about Papzimeos (zopapogene imadenovec-drba): The first and only FDA-approved treatment for RRP Approved for adults with RRP The only treatment to target the underlying cause of RRP Papzimeos is a non-replicating adenoviral vector-based immunotherapy designed to generate an immune response directed against papilloma cells expressing HPV 6/11 Delivered via four subcutaneous injections over a 12-week interval Patients can access Papzimeos SUPPORT for personalized services including insurance navigation, financial assistance, and ongoing access support, by calling (866) 827-8180. For Precigen's full release here: Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis For those interested in learning more about resources available to individuals affected by RRP, visit Renewed hope and continued commitment The FDA full approval of Papzimeos is a monumental step forward for the RRP community, but it is not the final destination. RRPF remains deeply committed to advancing research for all patients – including pediatric patients, who continue to face burdens of this disease without an approved therapeutic option, and patients around the world. This milestone fuels our resolve and fortifies our determination to see a future where all people living with RRP have the same hope realized. With strengthened movement, we will continue to advocate, collaborate, and push for the science that brings healing at every age and to every corner of the world. About RRPF The Recurrent Respiratory Papillomatosis Foundation (RRPF) was born from a parent's urgent need to understand and confront a rare, chronic, and potentially life-threatening disease affecting their child. Since 1991, RRPF has been a lifeline for patients and families navigating the isolating journey of RRP – offering connection, advocacy, and hope. What began as a grassroots effort has grown into a mission-driven organization united by the voices of parents, patients, and researchers. RRPF provides vital resources including access to the latest research, updates on clinical trials and medical meetings, and a supportive community for those affected by RRP. The foundation has played a pivotal role in advancing scientific understanding of RRP – contributing to research as authors, funders, and collaborators across multiple studies and initiatives. RRPF honors the legacy of those like Jennifer Woo, a former president of RRPF whose life and career were dedicated to curing RRP, and continues to drive forward research, awareness, and support for all those impacted. While we breathe, we hope. Learn more here: View source version on Contacts Media:Kim McClellan, President RRPF(331) 826-9050kimmc@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

IKS Health Wins Google Cloud Award for its Care Enablement Platform for Augmenting Human Expertise with AI
IKS Health Wins Google Cloud Award for its Care Enablement Platform for Augmenting Human Expertise with AI

Yahoo

time3 hours ago

  • Yahoo

IKS Health Wins Google Cloud Award for its Care Enablement Platform for Augmenting Human Expertise with AI

DALLAS, August 15, 2025--(BUSINESS WIRE)--IKS Health, a global leader in care enablement solutions supporting clinicians, staff, and patients at every step of the care journey, is proud to announce its Care Enablement Platform has won a Google Cloud 2025 DORA Award for "Augmenting Human Expertise with AI." IKS Health's Care Enablement Platform is a technology-powered ecosystem that combines advanced automation, data intelligence, and human expertise to offload administrative, clinical, and operational tasks. Its unique human + AI model is a seamless fusion of intelligent automation with domain-expert intervention to ensure accuracy and empathy. "Our goal is to alleviate the increasing administrative and operational burdens faced by clinicians, and our team is proud to achieve recognition from Google Cloud for our AI-human hybrid model that delivers superior accuracy, empathy, and trust compared to standalone automation," said Vijay Venkatesan, Chief Technology Officer, IKS Health. Google Cloud's DORA Awards celebrate the technical excellence and elite performance that is possible with software development and delivery. The IKS Health AI + human model accelerates delivery, cuts delays, reduces errors, and minimizes downtime, driving faster innovation and more reliable operations. "We are honored to receive such a prestigious award from Google Cloud for our advanced work in the 'Augmenting Human Expertise with AI' category," said Sachin K. Gupta, Founder and Global CEO, IKS Health. "Validation of our goal to create a platform-based solution that healthcare organizations can rely on to scale operations fuels us to continue the work of transforming healthcare so that clinicians can focus on their core work." About IKS Health IKS Health takes on the chores of healthcare — spanning administrative, clinical, and operational burdens — so that clinicians can focus on their core purpose: delivering great care. Combining pragmatic technology and dedicated experts, IKS Health enables stronger, financially sustainable enterprises. IKS Health's Care Enablement Platform delivers data-driven value and expertise across the care journey, and IKS Health is a partner for clinician enterprises looking to effectively scale, improve quality, and achieve cost savings through forward-thinking solutions. Founded in 2006, IKS Health's global workforce supports large health systems across the United States. For more information on IKS Health and its solutions, please visit Inventurus Knowledge Solutions Limited is listed on National Stock Exchange of India Limited (NSE) and BSE Limited (BSE). {Scrip codes: NSE - IKS and BSE - 544309} View source version on Contacts MEDIA CONTACT - IKS HEALTH Jill Gross, Director of Public Relationspress@

Next Health Announces Calabasas Expansion With Grand Opening August 15, 2025
Next Health Announces Calabasas Expansion With Grand Opening August 15, 2025

Business Wire

time4 hours ago

  • Business Wire

Next Health Announces Calabasas Expansion With Grand Opening August 15, 2025

WOODLAND HILLS, Calif.--(BUSINESS WIRE)--Next Health, the world's most advanced brand of proactive healthcare centers, is expanding its Los Angeles footprint with a new flagship location in Calabasas. Doors are already open, with an official Grand Opening celebration set for Friday, August 15, 2025. This expansion supports Next Health's mission to bring health optimization and longevity to the most strategic wellness-forward markets in the U.S., empowering individuals to take a proactive approach to their health. Next Health, the world's most advanced brand of proactive healthcare centers, is expanding its Los Angeles footprint with a new flagship location in Calabasas. The Grand Opening will feature a ribbon-cutting ceremony and exclusive wellness panel moderated by Next Health Founder and CEO Dr. Darshan Shah, who will lead a discussion on the future of longevity. He will be joined by wellness entrepreneur, fitness icon, and long-time Next Health supporter Brooke Burke, who will share insights into her personal health journey and the lifestyle practices that fuel her approach to longevity and vitality. The Calabasas location is led by powerhouse franchise partners Barry and Lori Turbow, along with Donnie and Megan Wilson —experienced entrepreneurs whose careers span success in sports marketing, business development, and healthcare. For Lori, a trained occupational therapist, the venture is deeply personal, shaped by her own experience navigating chronic illness and a lifelong passion for helping others reclaim their health. 'We're proud to bring Next Health to Calabasas—a community that embodies innovation, vitality, and a deep commitment to wellness,' said Barry and Lori Turbow. 'After years of working in healthcare and overcoming personal challenges, we knew we wanted to create a space where people can take charge of their longevity, access breakthrough medical technologies, and experience proactive health in a whole new way.' The center offers a comprehensive suite of services, including IV Therapy, hormone optimization, peptide therapy, hyperbaric oxygen chamber, weight optimization programs, cryotherapy, ozone therapy (including EBOO: Extracorporeal Blood Oxygenation and Ozonation), Therapeutic Plasma Exchange (TPE), and Next Health's most advanced longevity protocols like Executive Physicals, Biological Age Testing, and extensive functional medicine testing. Calabasas was chosen for its concentration of health-conscious residents, influential wellness culture, and demand for proactive medical solutions in a luxury setting. The new location reflects the collaborative vision of Dr. Darshan Shah, CEO and Founder of Next Health, and Kevin Peake, President, who continue to guide the brand's rapid national expansion through carefully selected franchise partners. 'Next Health Calabasas will serve as a beacon of health optimization in Southern California,' said Shah and Peake in a joint statement. 'We are thrilled to partner with Barry and Lori Turbow and Donnie and Megan Wilson to introduce cutting-edge longevity services to this remarkable community. Our goal is to empower individuals to take control of their health and extend the human healthspan through personalized, data-driven care.' Next Health Calabasas is located in the El Camino Shopping Center, offering a state-of-the-art, hospitality-grade facility designed to make advanced wellness accessible, empowering, and luxurious. Guests are invited to experience the future of health firsthand, with personalized consultations, immersive programming, and exclusive opening-week specials to mark the occasion. Location: 23383 Mulholland Dr, Woodland Hills, CA 91364 About Next Health Next Health is a pioneer in personalized health optimization and longevity. Founded in 2016 by renowned surgeon Dr. Darshan Shah and entrepreneur Kevin Peake, the brand blends advanced medical innovation with hospitality-grade experiences to help people live healthier, longer lives. Through services like IV therapy, hormone optimization, peptide treatments, cryotherapy, and extensive functional medicine testing, Next Health empowers people to take control of their vitality from the inside out.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store